Last reviewed · How we verify

NCT07082075

Joint Hyperlaxity and Volar Plate Dynamics: MRI-Based Comparative Evaluation of the PIP Joint

Completed Last updated 24 July 2025
What this trial tests

trial in Hypermobility, Joint in 32 participants. Completed in 15 May 2024.

Timeline
15 May 2023
Primary endpoint
15 July 2023
15 May 2024

Quick facts

Lead sponsorHacettepe University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment32
Start date15 May 2023
Primary completion15 July 2023
Estimated completion15 May 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 to 65, any sex, with Hypermobility, Joint. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: The volar plate (VP) is a key stabilizer of the proximal interphalangeal joint (PIPJ), and its biomechanical behavior may be altered in individuals with joint hypermobility. Objective: This study aimed to evaluate the spatial dynamics of the VP and its relationship with the center of joint motion and flexor digitorum profundus (FDP) tendon in individuals with and without joint hyperlaxity using MRI. Methods: Thirty-two healthy volunteers (16 hyperlax, 16 controls) underwent MRI imaging of both index fingers at five flexion angles (0°, 30°, 60°, 90°, full flexion) and under passive and isometric loading conditions. Key parameters measured included distances from the joint center to VP attachments, VP-FDP tendon distance, and the length between VP ends.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypermobility, Joint

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07082075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing